An Alzheimer’s Cure May Be On the Horizon—But Only With Right-Sized Regulations
The FDA could and should be more open-minded in evaluating the evidence in its drug approval decisions.
Understanding Elizabeth Warren’s Radical Wealth Tax
Warren’s proposed wealth taxes will have devastating consequences on capital formation.
Why Don’t Climate Change Alarmists Promote Nuclear Power?
If we need to take action now to reduce greenhouse gas emissions, there is no surer way to do it than to build nuclear power plants.
Three Encouraging Takeaways from the State of College Admissions
At least in some ways, higher education is learning from its mistakes and is improving its admissions processes for tomorrow’s applicants.
Is There a Model Zoning Code?
Zoning Has Done More Harm than Good in America. But the Code Rewrite in Bastrop, TX Takes Zoning in a More Liberalized Direction.
How can zoning be reformed to better enable market outcomes and reduce its high social costs?
New FDA Commissioner, Same FDA Problem
The most beneficial regulations the new FDA commissioner can implement, by far, will be restrictions on the FDA itself.
Myth-Busting: Small Business Edition
Contrary to what many Millennials believe, the business community isn’t here to ruin Christmas.
Neo-Noir “Motherless Brooklyn” Puts Power, Corruption at Center of Urban Renewal Story
Motherless Brooklyn might well contend for the most pro-liberty film to come out of Hollywood in 2019.
An International Agency Could Erode American Liberties on U.S. Taxpayers’ Dime
Attorney-client privilege is a cornerstone of Western law and is worth preserving.